1. Home
  2. FNWB vs RVPH Comparison

FNWB vs RVPH Comparison

Compare FNWB & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

HOLD

Current Price

$9.35

Market Cap

87.9M

Sector

Finance

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.29

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWB
RVPH
Founded
1923
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.9M
71.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
FNWB
RVPH
Price
$9.35
$0.29
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$13.50
$3.33
AVG Volume (30 Days)
35.2K
8.4M
Earning Date
01-28-2026
11-13-2025
Dividend Yield
1.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$54,052,000.00
N/A
Revenue This Year
$31.86
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.47
N/A
52 Week Low
$6.05
$0.25
52 Week High
$12.10
$2.17

Technical Indicators

Market Signals
Indicator
FNWB
RVPH
Relative Strength Index (RSI) 34.70 30.18
Support Level $9.30 $0.27
Resistance Level $10.08 $0.34
Average True Range (ATR) 0.12 0.06
MACD -0.10 -0.04
Stochastic Oscillator 3.82 9.29

Price Performance

Historical Comparison
FNWB
RVPH

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: